Fosrenol and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fosrenol (lanthanum carbonate) and Ranitidine (ranitidine). Common drug interactions include sinus tachycardia among females and peripheral arterial occlusive disease among males.

The phase IV clinical study analyzes what interactions people have when they take Fosrenol and Ranitidine. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Fosrenol?

Fosrenol has active ingredients of lanthanum carbonate. eHealthMe is studying from 5,922 Fosrenol users. Check the latest studies of Fosrenol.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.



On Jul, 12, 2026

37 people who take Fosrenol and Ranitidine together, and have interactions are studied.

Fosrenol and Ranitidine drug interactions.

What are the common drug interactions of Fosrenol and Ranitidine, by gender? *:

female:

  1. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  2. Skin ulcer
  3. Tricuspid valve incompetence (inefficient heart valve)
  4. Acute myocardial infarction (acute heart attack)
  5. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Device related infection
  8. Dystonia (abnormal muscle tone)
  9. Emotional disorder
  10. Epistaxis (bleed from the nose)

male:

  1. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  2. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  3. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  4. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  5. Drug ineffective
  6. Glaucoma (increased fluid pressure in the eye with vision loss)
  7. Headache (pain in head)
  8. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  9. Pyoderma (any skin disease that is pyogenic)
  10. Blood potassium decreased

What are the common drug interactions of Fosrenol and Ranitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Alopecia (absence of hair from areas of the body)
  2. Blindness
  3. Blood glucose increased
  4. Decreased activity
  5. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  6. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  7. Drug ineffective
  8. Glaucoma (increased fluid pressure in the eye with vision loss)
  9. Renal failure (kidney dysfunction)
  10. Hypertension (high blood pressure)

40-49:

  1. Essential hypertension (primary hypertension)
  2. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  3. Headache (pain in head)
  4. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
  5. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  6. Kidney infection
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Parathyroid tumour benign (parathyroid tumour non-cancerous)
  9. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  10. Pyelonephritis (inflammation of kidney caused by bacteria)

50-59:

  1. Headache (pain in head)
  2. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  3. Acute myocardial infarction (acute heart attack)
  4. Chronic kidney disease
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal failure (kidney dysfunction)
  7. Renal impairment (severely reduced kidney function)
  8. Sudden death

60+:

  1. Fall
  2. Anaemia (lack of blood)
  3. Vomiting
  4. Asthenia (weakness)
  5. Bell's palsy (facial paralysis)
  6. Cardiac failure
  7. Cardiac murmur (an heart sound in valve abnormality)
  8. Cardioactive drug level increased
  9. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  10. Cerebral circulatory failure (failure of brain blood circulation)

What are the existing conditions these people have? *

  1. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 10 people, 27.03%
  2. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 7 people, 18.92%
  3. Thyroid Diseases: 6 people, 16.22%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 13.51%
  5. Constipation: 5 people, 13.51%
  6. Blood Phosphorus Increased: 5 people, 13.51%
  7. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 4 people, 10.81%
  8. Dyslipidaemia (abnormal amount of lipids): 4 people, 10.81%
  9. Sleep Disorder: 3 people, 8.11%
  10. Peripheral Ischaemia (impaired circulation to an extremity): 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Fosrenol and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fosrenol and Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fosrenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fosrenol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lanthanum carbonate and ranitidine (the active ingredients of Fosrenol and Ranitidine, respectively), and Fosrenol and Ranitidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: